Table 1:
Animal # | Site | Target Energy Dose | No. of Pulses Delivered | Peak Heart Rate (bpm) | Blood Pressure S/D/M (mmHg) | AERP HRA (ms) | AERP CS (ms) | AERP LAA (ms) |
---|---|---|---|---|---|---|---|---|
1 | Baseline | N/A | N/A | 113 | 79/51/60 | 80 | 120 | 130 |
OSGP | 1000 V 100 μs | 10 × 3 | 121 | 152/110/124 | 60 | 120 | 130 | |
RSGP | 1000 V 100 μs | 10 × 3 | 142 | 182/141/155 | 50 | 120 | 170 | |
TSGP | 1000 V 100 μs | 10 × 3 | 111 | 163/112/129 | 50 | 120 | 170 | |
LSGP | 1000 V 100 μs | 10 × 3 | 127 | 174/137/149 | 60 | 120 | 170 | |
LMGP | 1000 V 100 μs | 10 × 3 | 121 | 127/93/104 | 70 | 120 | 190 | |
2 | Baseline | N/A | N/A | 104 | 75/45/55 | 60 | 100* | 60 |
OSGP | 1000 V 100 μs | 10 × 3 | 108 | 102/68/79 | 60 | 130 | 90* | |
RSGP | 1000 V 100 μs | 10 × 3 | 162 | 111/74/86 | 90* | 130 | 120* | |
TSGP | 1000 V 100 μs | 10 × 3 | 164 | 110/77/88 | 50 | 90 | 110 | |
LSGP | 1000 V 100 μs | 10 × 3 | 141 | 82/58/66 | 60 | 110 | 100 | |
LMGP | 1000 V 100 μs | 10 × 3 | 138 | 125/86/99 | 80 | 130 | 120 | |
3 | Baseline | N/A | N/A | 117 | 81/67/72 | 70 | 80 | 130 |
OSGP | 1000 V 100 μs | 10 × 6 | 111 | 240/172/195 | 100 | 80 | 140 | |
RSGP | 1000 V 100 μs | 10 × 6 | 128 | 238/168/191 | 110 | 110 | 130 | |
TSGP | 1000 V 100 μs | 10 × 6 | 123 | 195/148/164 | 130 | 120 | 130 | |
LSGP | 1000 V 100 μs | 10 × 6 | 133 | 182/142/155 | 100 | 100 | 160 | |
LMGP | 1000 V 100 μs | 10 × 6 | 122 | 162/126/138 | 110 | 90 | 140 | |
4 | Baseline | N/A | N/A | 94 | 106/63/77 | 90 | 120 | 90 |
OSGP | 1000 V 100 μs | 10 × 6 | 107 | 156/120/132 | 120 | 150 | 110 | |
RSGP | 1000 V 100 μs | 10 × 6 | 116 | 145/111/122 | 130 | 130 | 90 | |
TSGP | 1000 V 100 μs | 10 × 6 | 114 | 139/113/122 | 120 | 110 | 100 | |
LSGP | 1000 V 100 μs | 10 × 6 | 98 | 129/120/123 | 120 | 120 | 150 | |
LMGP | 1000 V 100 μs | 10 × 6 | 84 | 124/98/106 | 100 | 130 | 120 | |
5 | Baseline | N/A | N/A | 152 | 80/55/63 | 120 | 100 | 110 |
OSGP | 1000 V 100 μs | 10 × 6 | 137 | 81/56/64 | 140 | 130 | 150 | |
RSGP | 1000 V 100 μs | 10 × 6 | 128 | 95/54/68 | 170 | 100 | 120 | |
TSGP | 1000 V 100 μs | 10 × 6 | 142 | 110/72/85 | 150 | 100 | 130 | |
LSGP | 1000 V 100 μs | 10 × 6 | 144 | 101/62/75 | 130 | 100 | 140 | |
LMGP | 1000 V 100 μs | 10 × 6 | 149 | 96/65/75 | 110 | 110 | 110 |
Abbreviations: AERP, atrial effective refractory period; CS, coronary sinus; HRA, high right atrium; LAA, left atrial appendage; LMGP, ligament of Marshall ganglionated plexi; LSGP, left superior ganglionated plexi; OSGP, oblique sinus ganglionated plexi; RSGP, right superior ganglionated plexi; S/D/M, systolic/diastolic/mean; TSGP, transverse sinus ganglionated plexi. Vital signs and atrial effective refractory period response are stratified by each experimental animal and each energy delivery site. *Denotes values that were likely higher than the actual AERP due to pacing-induced arrhythmia interfering with interpretation.